US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary: market research reports

RSS Feeds

Respiratory/Pulmonary market research reports and industry analysis

1    3    5  6  7  8  9  10  
Acute Lung Injury - Pipeline Review, H1 2014
5/21/2014 | published by: Global Markets Direct
... information on the therapeutic development for Acute Lung Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
5/26/2014 | published by: GlobalData
... Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status ...  |  read more...
USD 2,500
Market Highlights: Italy Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Italy. The research includes Italy chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Germany Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: France Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Italy Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Japan Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: US Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... the US bronchitis market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research ...  |  read more...
USD 990
Update: Chronic Obstructive Pulmonary Disease Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... Pulmonary Disease market. It covers emerging therapies for Chronic Obstructive Pulmonary Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking ...  |  read more...
USD 590
Market Highlights: Spain Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Spain. The research includes Spain chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: UK Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in UK. The research includes UK chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Germany Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Germany. The research includes Germany chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Japan Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Japan. The research includes Japan chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Europe Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... disease drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six ...  |  read more...
USD 2,800
Update: Cystic Fibrosis Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Update: Small Cell Lung Cancer Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... Lung Cancer market. It covers emerging therapies for Small Cell Lung Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking ...  |  read more...
USD 590
Update: Pulmonary Hypertension Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Pulmonary Hypertension in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Idiopathic pulmonary fibrosis – on the cusp of a revolution; how will forthcoming approvals shape the treatment and development landscapes? - Physician Views
5/27/2014 | published by: FirstWord
... pulmonary fibrosis (IPF). Positive Phase III data are expected to act as the springboard for FDA approvals of InterMune's Esbriet (pirfenidone) and Boehringer Ingelheim's nintedanib by late 2014/early 2015. Launch and uptake of these products ...  |  read more...
USD 645
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
1/20/2014 | published by: FirstWord
... a 5 year CAGR of 7.1% this high growth sector is set for radical change as new products and combinations are introduced changing both the treatment and competitive landscapes. The cosy carve up of the ...  |  read more...
USD 7,495
Asthma and COPD Therapies: World Market 2013-2023
9/6/2013 | published by: Visiongain
... to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall world market, submarket, product, company and national level. You see why the asthma and COPD ...  |  read more...
USD 2,837
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth
2/7/2014 | published by: GBI Research
... “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth”. The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value ...  |  read more...
USD 4,995
Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2013
9/5/2013 | published by: GlobalData
... 2013 provides data on the Adult Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndrome. It includes an overview of the ...  |  read more...
USD 2,500
Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013
10/31/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Acute Lung Injury Global Clinical Trials Review, H2, 2013
10/31/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Acute Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
1    3    5  6  7  8  9  10